Xinyu Han

Title: Xinyu Han: Innovator in Biomedicine

Introduction

Xinyu Han is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biomedicine, particularly in the area of drug resistance prediction. His innovative work has the potential to impact treatment strategies for patients with diffuse large B cell lymphoma.

Latest Patents

Xinyu Han holds a patent titled "Biomarker for predicting drug resistance of bruton's tyrosine kinase inhibitors and application thereof." This patent focuses on a biomarker that can predict drug resistance to BTK inhibitors, specifically in diffuse large B cell lymphoma cells. The biomarker identified in his research is either SMPD1 or SPHK1. This discovery is crucial for predicting the sensitivity of lymphoma cells to BTK inhibitors, which can lead to more effective treatment options.

Career Highlights

Throughout his career, Xinyu Han has worked with several esteemed institutions. He has been associated with Beijing Friendship Hospital and Capital Medical University, where he has contributed to various research initiatives. Additionally, he has worked at Beijing Roborock Technology Co., Ltd., further showcasing his versatility and expertise in the field.

Collaborations

Xinyu Han has collaborated with notable colleagues, including Yiqun Che and Junhao Wei. These partnerships have enhanced his research and contributed to the advancement of biomedicine.

Conclusion

Xinyu Han's innovative work in identifying biomarkers for drug resistance represents a significant advancement in the field of biomedicine. His contributions have the potential to improve treatment outcomes for patients facing challenging conditions.